BB Biotech as of March 31, 2013
Portfolio Holdings for BB Biotech
BB Biotech holds 19 positions in its portfolio as reported in the March 2013 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Celgene Corporation | 20.8 | $263M | 2.3M | 115.91 | |
| Gilead Sciences (GILD) | 15.2 | $192M | 3.9M | 48.94 | |
| ISIS Pharmaceuticals | 10.3 | $130M | 7.7M | 16.94 | |
| Incyte Corporation (INCY) | 9.8 | $124M | 5.3M | 23.41 | |
| Vertex Pharmaceuticals Incorporated (VRTX) | 7.3 | $92M | 1.7M | 54.97 | |
| Alexion Pharmaceuticals | 5.2 | $66M | 717k | 92.14 | |
| Medivation | 4.6 | $58M | 1.2M | 46.76 | |
| ImmunoGen | 4.3 | $55M | 3.4M | 16.07 | |
| Ariad Pharmaceuticals | 4.1 | $52M | 2.9M | 18.08 | |
| Onyx Pharmaceuticals | 3.8 | $49M | 547k | 88.86 | |
| Medicines Company | 2.6 | $33M | 988k | 33.41 | |
| Halozyme Therapeutics (HALO) | 2.6 | $33M | 5.6M | 5.76 | |
| Endocyte | 2.3 | $29M | 2.3M | 12.45 | |
| BioMarin Pharmaceutical (BMRN) | 2.0 | $26M | 417k | 62.26 | |
| Theravance | 1.7 | $21M | 888k | 23.62 | |
| Optimer Pharmaceuticals | 1.4 | $17M | 1.4M | 11.90 | |
| Achillion Pharmaceuticals | 1.2 | $15M | 1.7M | 8.75 | |
| Dendreon Corporation | 0.5 | $6.0M | 1.3M | 4.74 | |
| Idenix Pharmaceuticals | 0.3 | $4.4M | 1.3M | 3.54 |
